| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 111,422 | 85,334 | 90,214 | 156,718 | | Cost of Revenue | 69,778 | 53,106 | 58,148 | 102,546 | | | Gross Profit | 41,644 | 32,228 | 32,066 | 54,172 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 33,374 | 31,457 | 34,615 | 53,911 | | Non Recurring | 671 | (663) | 824 | 39,810 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,599 | 1,434 | (3,373) | (39,549) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 7,599 | 1,434 | (3,373) | (39,549) | | Interest Expense | 3,294 | 2,894 | 2,873 | 2,741 | | Income Before Tax | 4,305 | (1,460) | (6,246) | (42,290) | | Income Tax Expense | 153 | 281 | 135 | (2,983) | | Minority Interest | (910) | 910 |
-
|
-
| | | | Net Income From Continuing Ops | 4,879 | (1,253) | (5,959) | (39,175) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,879 | (1,253) | (5,959) | (39,175) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,879 | ($1,253) | ($5,959) | ($39,175) |
|
0.03% Nasdaq 0.00%
Income Statement
